The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5, for emergency use in people ages 12 and up. The Centers for Disease Control and ...

The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older. The Novavax vaccine is protein ...

The vaccine against COVID-19 being developed and tested by Novavax has been accepted for rolling review by the European Medicines Agency (EMA). The vaccine, NVX-CoV2372, is in Phase 3 clinical trials ...

By Michael Erman and Siddhi Mahatole May 6 (Reuters) - Novavax on Wednesday beat Wall Street estimates for first-quarter revenue, as milestone payments from vaccine supply and licensing deals helped ...

Find the latest covid-19 vaccine news from Fast company. See related business and technology articles, photos, slideshows and ...

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that's been cleared for use in adults in parts of the ...

IOWA CITY — News this week that Americans now have a fourth COVID-19 vaccine option — one closer to more traditional vaccines used to combat flu, for example — came about thanks, in part, to ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2. The U.S. Health and ...

There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 2 min It’s the second time the firm ...